Cytostatics and monoclonal antibodies are central pillars in tumor treatment. The basic substances are produced by the pharmaceutical industry, while the patient-specific ...
In June 2022 schülke joined the Science Based Targets Initiative (SBTi) which shows the company’s clear focus on further advancing its climate protection activities based on the ...
Norderstedt, November 03, 2023. Schülke & Mayr TopCo GmbH ("schülke" or "the company") today announced the successful completion of the change of ownership from EQT Private ...
Norderstedt, 01. November 2023. mikrozid® universal wipes* green line are now also available in maxi format. The new format (23x25 cm) of the medical disinfection wipes is ...
The Schülke & Mayr GmbH (schülke) has as Group once again successfully passed the Ecovadis scoring and was able to significantly improve its result in the year of 2023: ...
schülke, a leading global provider of infection prevention and hygiene solutions in healthcare, acquires Spanish company Vesismin Health, expert in infection control in the ...
schülke and HP are expanding the possibilities for ensuring the highest level of hygiene at workplaces as part of a partnership. For the disinfection of selected HP computers, ...